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stressMorgana/CHP-1 (CHORD containing protein-1) has been recently shown to be necessary for proper cell
divisions. However, the presence of the protein in postmitotic tissues such as brain and striated muscle
suggests that morgana/CHP-1 has additional cellular functions. Here we show that morgana/CHP-1 behaves
like an HSP90 co-chaperone and possesses an independent molecular chaperone activity towards denatured
proteins. The expression time proﬁle ofmorgana/Chp-1 in NIH3T3 cells in response to heat stress is similar to
that of Hsp70, a classical effector of Heat Shock Factor-1 mediated stress response. Moreover, overexpression
of morgana/CHP-1 in NIH3T3 cells leads to the increased stress resistance of the cells. Interestingly,
morgana/Chp-1 upregulation in response to transient global brain ischemia lasts longer in ischemia-resistant
regions of the gerbil hippocampus than in vulnerable ones, suggesting the involvement of morgana/CHP-1 in
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Morgana/CHP-1 (CHORD containing protein-1) has been recently
described as a regulator of centrosome duplication and maintenance
of genomic stability in Drosophila and mouse [1]. It is ubiquitously
expressed [2] and its presence in postmitotic tissues such as brain and
skeletal muscles suggests that it may function beyond regulating cell
divisions. The protein contains two highly evolutionarily conserved
CHORD (Cys and His Rich Domain) domains, ﬁrstly identiﬁed in Rar-1,
a plant protein involved in pathogen resistance signaling [3]. The C-
terminus of morgana/CHP-1 contains a CS domain (CHORD contain-
ing protein and Sgt1 domain), which is typical for small heat shock
proteins as α-crystallin and for HSP90 co-chaperone proteins—p23
and SGT1 [4]. In vertebrates there is another homolog of Rar1 [2],melusin, which is expressed only in skeletal and cardiac muscles [5,6]
and required for compensatory cardiac remodeling in response to
pressure overload [7,8]. Non-vertebrates carry only one gene coding
for a CHORD containing protein [3] showing a higher degree of
homology with vertebrate morgana/CHP-1 than with melusin [2].
Morgana/Chp-1 gene expression is regulated by HSF-1 (Heat Shock
Factor-1) in response to elevated temperature [9] and the protein
interacts with molecular chaperone HSP90 [1,10–12].
Here we demonstrate that morgana/CHP-1 behaves like an HSP90
co-chaperone, possesses chaperone activity per se, and protects cells
from cell death induced by different stress stimuli. Moreover,
morgana/CHP-1 expression is increased in gerbil hippocampus after
transient global brain ischemia suggesting its involvement in stress
response in vivo.
2. Materials and methods
2.1. Antibodies and immunoblot procedure
Cells were washed twice with PBS, scraped and resuspended in
lysis buffer containing 20 mM Tris–HCl pH 7.5; 150 mM NaCl; 0.1%
Triton X-100; 1 mMDTT; 2 mMNaF; phosphatase inhibitors cocktail 2
(Sigma) and complete EDTA-free protease inhibitors cocktail (Roche).
Samples were next subjected to 3 cycles of freezing in liquid nitrogen
and thawing at 37 °C. The resulting lysate was then centrifuged at
Fig. 1. Morgana/CHP-1 interacts with HSP90 as its co-chaperone. (A) Co-immunopre-
cipitation of the endogenous morgana/CHP-1 and HSP90 from the NIH3T3 protein
extract. Morgana/CHP-1 was immunoprecipitated with a speciﬁc monoclonal antibody
from the total NIH3T3 cell extract (TE). Unrelated mouse IgG was used as a control of
the immunoprecipitation speciﬁcity. Immunoblot analysis was performed using anti
HSP90 antibody. The experiment was performed 3 times, with the same result. (B)
Representative western blot showing the effect of the HSP90 inhibitor radicicol on the
level of morgana/CHP-1 and Raf-1 in NIH3T3. Cells were treated for 24 hwith indicated
concentrations of radicicol. Total cell extracts were analyzed by immunoblot using
speciﬁc antibodies. β-actin was used as a loading control. (C) Densitometric
quantiﬁcation of morgana/CHP-1 protein level in NIH3T3 cells in response to radicicol
treatment. Bars represent mean fold changes in respect to the mock-treated cells
(white bar) of ﬁve independent experiments. In each experiment the intensities of
morgana/CHP-1 bands were normalized to β-actin. Error bars indicate S.E.M.; *pb0.05 ;
**pb0.01; ***pb0.001 (one-way analysis of variance, Newman–Keuls post-test).
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with Bradford assay (Bio-Rad). 15 µg of total protein were resolved in
the denaturing 10% polyacrylamide gels. After electrophoresis
proteins were electrotransferred on the nitrocellulose membranes.
Membranes were next blocked with a 5% solution of non-fat milk in
Tris-buffered saline containing 0.1% Tween (TBST) for 1 h at RT.
Incubation with solutions of primary antibodies in a blocking solution
was carried out overnight at 4 °C. Next, membranes were washed
three times with TBST, and incubated with a TBST solution of a
secondary horseradish conjugated antibody for 45 min at RT.
Membranes were washed three times with TBST. The signal was
detected on a photographic ﬁlm using chemiluminescence. The
intensity of the bands was quantiﬁed using a GS-800 Calibrated
Densitometer and the Quantity One software (Biorad).
Anti morgana/CHP-1 monoclonal antibody (P1PP0) was generat-
ed in our laboratory using GST-morgana/CHP-1 fusion protein as an
antigen [1]. Other commercially available antibodies were used: anti
HSP70 (Stressgen, SPA-812, WB 1:5000), anti HSP90 (Stressgen, SPA-
835, 1:1000), anti Raf-1 (Santa Cruz, sc-227, 1:1000), anti GFP
(Roche), anti β-actin (Sigma, A5441, 1:50000), HRP conjugated anti
mouse, rabbit and rat IgG (Sigma A9044, A0545, A9037 respectively).
2.2. Expression plasmids and recombinant protein production
To obtain recombinant full-length CHP-1 (aa 1–331) and isolated
CHORD (aa 1–224) and CS (aa 225–331) domains, respective coding
sequences were inserted into pGEX-5X-3 plasmid (GE Healthcare).
DNA fragments were generated by PCR using speciﬁc primers
containing EcoRI and SmaI recognition sites and previously described
pMALc2-Chp-1 as a template [2]. Protein production was carried out
in 2 l cultures of Escherichia coli BL21 Rosetta strain. Expression was
induced with 0.4 mM IPTG at OD600=0.5 and bacteria were cultured
at 20 °C for 5 h. Bacterial pellets were resuspended in buffer contain-
ing 50 mM Hepes pH 7.5; 150 mM NaCl; 5% glycerol; 1 mM DTT,
20 μM ZnCl2; Complete EDTA-free protease inhibitors cocktail
(Roche), 1 mg/ml lysozyme and 1 μg/ml DNase and lyzed using
French press. Protein extracts obtained after centrifugation (150,000g,
40 min) were incubated with 1 ml of glutathione Sepharose (GE
Healthcare) for 2 h at 4 °C. Resins were then washed with 25 ml of
buffer A (50 mMHepes pH 7.5; 150 mMNaCl; 5% glycerol; 1 mMDTT,
20 μM ZnCl2), 25 ml of buffer B (buffer A with 500 mM NaCl) and
again with 25 ml of buffer A. The protein was eluted with three 2-ml
portions of buffer A containing 10 mM reduced glutathione. Proteins
were dialyzed against 40 mM Hepes pH 7.5, concentrated and frozen
at −80 °C.
2.3. Cell culture and lentiviral transduction
NIH3T3 cells were purchased from ATCC. All cells were maintained
in high-glucose Dulbecco Modiﬁed Eagle's Medium (Invitrogen)
supplemented with 10% Fetal Bovine Serum (Sigma) and 1%
penicillin/streptomycin solution (Sigma). NIH3T3 stably overexpres-
singmorgana/CHP-1 or GFPwere obtained by infectionwith lentiviral
vectors carrying coding sequences of murine morgana/CHP-1 or
green ﬂuorescent protein (GFP). Pools of viral transformants were
used in all the experiments. Mock infected cells were produced as
additional control. High-titer lentiviral vector stocks were produced
as previously described [8]. Brieﬂy, 293 T packaging cells were seeded
at 40% conﬂuency in DMEM 10% FCS and incubated for 24 h at 37 °C,
5% CO2. The day after packaging cells were co-transfected, using
Effectene reagent (Qiagen), with the transfer vector (pCCLsin) the
packaging vectors (pMDL and pRSV.REV) and the envelope vector
(pMD2VSV-G). On the following day the medium was changed and
about 72 h after transfection the lentivirus containing medium was
collected and passed through a 0.22-μm ﬁlter. The virus was divided inaliquots and stored at −80 °C. Virus solutions supplemented with
8 μg/mL polybrene (Sigma) were used to infect NIH3T3.
2.4. Stress treatments
2.4.1. Heat-shock
For studies of gene expression, NIH3T3 cells were seeded in a 6-
well culture dish (3×105 cells per well). Two days later the dishes
were sealed with paraﬁlm and placed in a water bath at 43 °C for
45 min. Cells were allowed to recover for indicated times at 37 °C, 5%
CO2 before harvesting.
To study the effect of morgana/CHP-1 overexpression on the
viability of NIH3T3 cells in response to heat-shock, trypsinized cells,
resuspended in the full DMEM were incubated for 15 min in a water
bath at 43 °C. Control cells were incubated at 37 °C. Subsequently,
2×104 cells per well were seeded in a 96-well plate (BioCoat, Collagen
I Cellware 96-well white/clear plate, BD Labware). Cell viability was
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mega). The assay is based on a luminometric quantiﬁcation of ATP
present in live cells and released after addition of lysis reagent. The
viability was expressed as the ratio of mean luminescence intensity of
heat-shock treated to non-treated cells.2.4.2. Hydrogen peroxide
For gene expression analysis, cells were washed with PBS and
incubated with 100 μM H2O2 in a serum-free medium (Optimem,
Invitrogen) for 1 h at 37 °C, 5% CO2. Next, medium was exchanged for
the full DMEM and cells were let recover for indicated times at 37 °C,
5% CO2 before harvesting.
To compare the viability of morgana/CHP-1 overexpressing and
control NIH3T3 cells in response to H2O2, 2×104 cells per well were
seeded in a 96-well plate. On the following day cells were washed
with PBS and incubated with 250 μM H2O2 in Optimem (Invitrogen)
for 1 h at 37 °C, 5% CO2. The medium was then exchanged for serum
supplemented DMEM and cells were cultured for the following 16 h.
The viability was measured as in the case of the heat-shock treatment.2.4.3. Tunicamycin, etoposide and radicicol treatment
NIH3T3 cells were seeded in a 6-well plate as for heat-shock
treatment. Two days later they were incubated with 5 μg/ml
tunicamycin or 50 μM etoposide in a fresh DMEM for 3 h, 8 h and
24 h. In case of radicicol treatment, cells were incubated with 1.25; 2.5;
5; 10 μM radicicol for 24 h. After indicated times cells were collected for
RNA and/or protein extraction.Fig. 2. Morgana/CHP-1 has a chaperone activity in vitro. (A) Representative graph illustra
scattering measurements of 150 nM citrate synthase alone (■) and in the presence of GST- m
300 nM (O) or 150 nM GST (+) or BSA (×) were performed in 40 mMHEPES-KOH, pH 7.5, at
CHP-1 fragments used in the study. (C) Typical graph showing the effect of morgana/CHP
150 nM citrate synthase alone (■) and in the presence of equimolar concentrations of GS
40 mM HEPES-KOH, pH 7.5, at 43 °C. Three independent repeats of the experiment gave sim
equimolar concentration of GST-morgana/CHP-1, GST-CS, GST-CHORDs or GST at the 15-m
experiments and the error bars represent S.E.M. **pb0.01; ***pb0.001 (paired Student's t-t2.5. RNA isolation and real-time PCR
NIH3T3 cells were collected in PBS, pelleted and stored at−80 °C
until RNA isolation. RNA from NIH3T3 was isolated with RNeasy Kit
(Qiagen) and from gerbil brain tissue with RNeasy for Lipid Tissue
(Qiagen). RNA was additionally treated with DNase (Qiagen). The
cDNA (SuperScript III RNase H-Reverse Transcriptase, Invitrogen) was
examined by Real Time PCR in 7500 Real Time PCR System using the
SYBR-Green dye (Applied Biosystems). The results were analyzed by
the absolute quantiﬁcation with a relative standard curve. The
following primers were used:
for mouse and gerbil morgana/Chp-1: 5'AGGGTGTTCAAAGACA-
TACCAGGG, 5'TCTTGTACAGCCCTCTTGGGCTAA;
for mouse Hsp70.1, Hsp70.3: 5'TGCCTTCAACATGAAGAGCG,
5'TTGTGCACGAACTCCTCCTT;
for gerbil inducible Hsp70: 5'ATGACGTGCGACAACAACCTGCT,
5'TGATGGTGATCTTGTTGGCCTTGC;
for mouse and gerbil 18 S RNA: 5'AACGAACGAGACTCTGGCATG,
5'CGGACATCTAAGGGCATCACA.
2.6. Citrate synthase assay
The assay was performed as described by Buchner [13]. Porcine
citrate synthase (Sigma) was dialyzed against 50 mM Tris–HCl pH 8.0
and concentrated (Vivaspin 6 MWCO 10 k, Sartorius). Aggregation of
150 μM solution of citrate synthase in 40 mM HEPES-KOH pH 7.5 was
monitored by measuring light scattering at the wavelength of 360 nmting the effect of GST- morgana/CHP-1 on the aggregation of citrate synthase. Light
organa/CHP-1 at the following concentrations: 37 nM (▲), 75 nM (□), 150 nM (△) and
43 °C. Experiment was performed 3 times with similar results. (B) Scheme of morgana/
-1 domains on the aggregation of citrate synthase. Light scattering measurements of
T-morgana/CHP-1 (□), GST-CHORDs (△), GST-CS (▲) or GST (+) were performed in
ilar results. (D) Mean relative levels of citrate synthase aggregation in the presence of
in timepoint of the aggregation reaction. The bars show the mean of 3 independent
est).
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RF-5301). Proteins assayed for their chaperone properties were
dialyzed against 40 mM HEPES-KOH, pH7.5. Their thermal self-
aggregation was excluded by monitoring light scattering of tested
proteins solutions at 43 °C.
2.7. Co-immunoprecipitation
For immunoprecipitation, cells were lysed in NP-40 lysis buffer
(20 mM Tris–HCl pH 7.4, 150 mM NaCl, 0.5% NP-40, 10 mM NaF,
1 mM PMSF, 1 mM Na3VO4 and Complete EDTA-free protease
inhibitors cocktail (Roche). After centrifugation at 14,000 rpm for
10 min at 4 °C the supernatants were immunoprecipitated at 4 °C
with 5 μg of P1PP0 anti-morgana/CHP-1 antibody or control IgG.
Immune complexes were collected on 30 μl protein G-Sepharose
beads, and the beads were washed six times with ice-cold lysis buffer.
Bound proteins were recovered by boiling in Laemmli sample buffer
and resolved on SDS-PAGE as previously described.
2.8. Transient global brain ischemia and sample preparation
The Local Committee for Ethics in Animal Experiments approved all
the experimental procedures on male Mongolian gerbils weighing 50–
60 g. The ischemic insult was performed by 5 min ligation of the
common carotid arteries under halothane in N2O:O2 (70:30) anesthesia
in strictly controlled normothermic conditions as described previously
[14]. The cerebral blood ﬂow was monitored by laser Doppler
ﬂowmetry (Muro, Inc.), and only animals that during ischemia had
b6% of normal cortical blood ﬂow were used for the experiments.
Animals were allowed to recover for a period of 1, 3, 24 and 48 h and
then decapitated under halothane anesthesia. Sham-operated animals
served as controls. Control and post-ischemia hippocampi wereFig. 3. Morgana/Chp-1 expression is upregulated in NIH3T3 cells in response to heat-sho
expression in NIH3T3 cells at different time points after heat-shock (43 °C, 45 min). Bars rep
**pb0.01; ***pb0.001 (unpaired Student's t-test). (C) Representative immunoblot showing
shock. β-actin was used as a loading control. (D) Densitometric quantiﬁcation of morgana/C
morgana/CHP-1 protein in untreated (white bars) and heat-shocked (black bars) cells in
independent experiments. In each experiment the OD values of morgana/CHP-1 bands wereimmediately divided to CA1 and CA2–4, DG containing parts with a
ﬁssura hippocampalis taken as a starting orientation point and frozen at
−80 °C for subsequent RNA isolation.
3. Results
3.1. Morgana/CHP-1 behaves like an HSP90 co-chaperone
We performed a co-immunoprecipitation experiment with a
monoclonal antibody against morgana/CHP-1 using NIH3T3 protein
extracts, and evaluated the presence of HSP90 in the immunocomplex
by western blot. As shown in Fig. 1A, the endogenous HSP90 was
found in the immunoprecipitate. Therefore we conﬁrmed earlier
reports showing that the two proteins are able to interact [1,10–12].
HSP90 binding proteins belong to two different classes: HSP90
substrate proteins, whose stability often depends on HSP90 activity,
and so-called co-chaperones, which regulate substrate speciﬁcity or
ATP-ase activity of HSP90. Upon a treatment of cells with an HSP90
inhibitor e.g., radicicol, protein substrates of the HSP90 chaperoning
activity undergo degradation. At the same time, level of co-
chaperones remains stable or augments [15]. We incubated NIH3T3
cells with increasing concentrations of radicicol for 24 h and
examined the level of morgana/CHP-1. In response to the treatment,
morgana/CHP-1 was induced over two-fold, in a dose dependent
manner (Fig. 1B and C). Notably, the level of Raf1, which is a well
known HSP90 client protein [16], decreased. Thus morgana/CHP-1
behaves like a co-chaperone rather than a substrate of HSP90.
3.2. Morgana/CHP-1 CS domain possesses a chaperone activity
Some HSP90 co-chaperones have been reported to possess their
own molecular chaperone activity towards model protein substratesck. Real-time PCR analysis of (A) morgana/Chp-1 and (B) Hsp70 (Hsp70.1, Hsp70.3)
resent arithmetical means of at least 3 experiments. Error bars indicate S.E.M.; *pb0.05;
morgana/CHP-1 and HSP70 level in NIH3T3 cells at different time points after heat-
HP-1 protein level in NIH3T3 cells in response to heat-shock. Bars show relative level of
respect to the 3 h untreated control. Bars represent arithmetic means from seven
normalized to β-actin. Error bars indicate S.E.M.; **pb0.01 (unpaired Student's t-test).
Fig. 4. NIH3T3 cells overproducing morgana/CHP-1 are protected from stress. (A)
Representative immunoblot showing morgana/CHP-1, GFP and β-actin (as a loading
control) expression level in NIH3T3 cells infected with lentiviruses carrying MYC-
morgana or GFP as well as in mock infected cells. (B) Viability of NIH3T3 cells stably
overexpressing MYC- morgana/CHP-1 (black bar), GFP (hatched bar) and mock infected
cells (white bar) after heat-shock. Equal number of the cells were incubated in suspension
for 15 min at 43 °C, seeded on a 96-well microtiter plate and cultured for the following
16 h at 37 °C prior to cell viability measurement. The bars represent the mean relative
viability as the ratio of luminescence intensity of treated to non-treated cells from ﬁve
independent experiments. Error bars indicate S.E.M.; ***pb0.001 (unpaired Student's t-
test). (C) Viability of NIH3T3 cells stably overexpressing morgana/CHP-1 (black bar), GFP
(hatched bar), and mock infected cells (white bar) after hydrogen peroxide treatment.
Equal number of the cells were seeded on a 96-well microtiter plate and treated with
250 µM H2O2 for 1 h in a serum-free medium. Next, the medium was exchanged to a
serum supplemented one and the cells were cultured for the following 16 h prior to cell
viability determination. The bars represent the mean relative viability as the ratio of
luminescence intensity of treated to non-treated cells fromﬁve independent experiments.
Error bars indicate S.E.M.; ***pb0.001 (unpaired Student's t-test).
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investigated its ability to suppress the aggregation of citrate synthase,
a model thermolabile substrate. In this test we used a recombinant
GST-morgana/CHP-1 fusion protein. The addition of equimolar
quantity of GST-morgana/CHP-1 suppressed the heat induced
aggregation of citrate synthase. The chaperoning action of GST-
morgana/CHP-1 was dose dependent and speciﬁc since such proteins
as GST or BSA did not inhibit citrate synthase aggregation (Fig. 2A).
This result revealed that morgana/CHP-1 has an intrinsic chaperone
activity.
To map which of the morgana/CHP-1 domains possesses chaperone
activity, we produced GST fusion proteins containing morgana/CHP-1
CHORD and CS domains separately (Fig. 2B). As illustrated by a
representative graph in Fig. 2C, the isolated CS domain was able to
protect citrate synthase to a similar extent as the full-length protein,
while CHORDdomains did not showany chaperone activity. As shown in
Fig. 2D, both morgana/CHP-1 and the isolated CS domain suppress the
aggregation of citrate synthase by about 50% at the 15 min timepoint.
3.3. Morgana/Chp-1 expression is upregulated in response to heat-shock
in NIH3T3 cells
We examined themorgana/Chp-1 expression at the transcript and
protein level in response to a heat stress. When NIH3T3 cells were
incubated at 43 °C for 45 min and allowed to recover for different
times at 37 °C, the level of morgana/Chp-1 mRNA increased about 3
times 3 h after the heat-shock. Eight hours after the stress, the
transcript returned to the basal level (Fig. 3A). The kinetics of
morgana/Chp-1 expression resembled that of Hsp70, which is a
classical effector of HSF-1 dependent stress response (Fig. 3B). As
expected, the augmented level of morgana/Chp-1 mRNA was
accompanied by an increase of the protein level 3 h and 8 h after
heat-shock as revealed by immunoblot analysis (Fig. 3C, D).
Other stress stimuli, that were not able to induce Hsp70 in NIH3T3
cells, such as treatment with hydrogen peroxide, etoposide or
tunicamycin, did not increase morgana/Chp-1 expression (Supple-
lementary Figure).
3.4. Morgana/CHP-1 protects cells from stress induced death
To test whether morgana/CHP-1 may protect cells from stress, we
stably overexpressed morgana/CHP-1 or GFP in NIH3T3 using
lentiviral infection and subjected pools of the NIH3T3 viral transfor-
mants (Fig. 4A) to elevated temperature or hydrogen peroxide. The
cells overproducing morgana/CHP-1 were signiﬁcantly protected
from death induced by both types of stress, comparing to the control
cells (Fig. 4B and C).
3.5. Morgana/Chp-1 expression increases in gerbil hippocampus after
transient global brain ischemia
We next examined morgana/CHP-1 involvement in stress re-
sponse in vivo.Wemeasuredmorgana Chp-1mRNA level in the gerbil
hippocampus after transient brain ischemia, an injury known to cause
accumulation of damaged proteins and increased expression of
several heat shock proteins [19–22]. In this model neurons in the
CA1 (Cornu Ammonis 1) region of the hippocampus die 3–5 days after
ischemic episode, while neurons in region comprising CA2–4 and DG
(dentate gyrus) are resistant indicating there is an intrinsic neuro-
protective mechanism in the latter hippocampal region [23,24]. We
thus measured morgana/Chp-1 expression separately in CA1 and
CA2–4+DG parts of the hippocampus. Although 3 h after ischemia
morgana/Chp-1 expression was similarly elevated in both regions of
the hippocampus, this increase lasted differently in the two parts.
While in the ischemia sensitive CA1 region morgana/Chp-1 mRNA
returned to the basal level within 24 h, in the ischemia resistant CA2–4+DG the increase was prolonged and lasted over 24 h post ischemia
(Fig. 5A). The upregulation of Hsp70 was also longer in the ischemia-
resistant regions of the hippocampus (Fig. 5B). These results illustrate
that morgana/Chp-1 levels parallel the observed protection from
ischemia induced stress in this in vivo model.
4. Discussion
Morgana/CHP-1 is a phylogenetically conserved protein involved
in the regulation of centrosome duplication by inhibiting ROCK kinase
activity [1]. As morgana/CHP-1 is ubiquitously present in adult post-
Fig. 5. Proﬁle ofmorgana/Chp-1 expression is different in CA1 and CA2–4+DG regions of the gerbil hippocampus after transient global brain ischemia. (A) Real-time PCR analysis of
Morgana/Chp-1 and (B) Hsp70 (Hsp70.1, Hsp70.3)mRNA level in CA1 (dashed line) and CA2–4+DG (solid line) regions of gerbil hippocampi 1; 3; 24 and 48 h after 5 min ligation of
the common carotid arteries. Each point represents a mean value of relative mRNA levels from 3 different animals. Error bars indicate SEM; *pb0.05 for comparison between C (Sham
operated animals) and each time point (unpaired Student's t-test), #pb0.05 for comparison between CA1 and CA2–4+DG regions (paired Student's t-test). The scheme illustrates
the division of the hippocampus into two analyzed regions.
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regulation of cell divisions. Here we demonstrated a new role for
morgana/CHP-1 as a stress responsive protein possessing an intrinsic
chaperone activity and able to protect cells from death induced by
different stress stimuli.
As previously demonstrated [1,10–12], morgana/CHP-1 forms a
complex with HSP90 in mammalian cells. Here we propose that
morgana/CHP-1 is a co-chaperone, rather than a substrate protein of
HSP90, since its level increases in cells incubated with HSP90
inhibitor. Moreover, as other HSP90 co-chaperones [6,17,18], mor-
gana/CHP-1 possesses its own chaperone activity towards thermally
denatured citrate synthase. We have shown that this activity resides
in the CS domain of morgana/CHP-1. This ﬁnding is consistent with
the fact that the CS domain is present in other known HSP90 co-
chaperones, like p23 and SGT1 [4]. Moreover, the CS domain is
homologous to α-crystallin domain of small heat shock proteins,
which are believed to control aggregation and disaggregation of
denatured proteins in vivo [25]. Morgana/CHP-1 chaperone activity
suggests that this protein can protect cell from stress induced damage.
This idea is supported by our results showing that NIH3T3 cells
overexpressing morgana/CHP-1 are more resistant to death induced
by different stress stimuli, namely heat-shock and oxidative stress.
Consistent with this ﬁnding we show that morgana/Chp-1 gene
expression as well as the protein level is increased about 3-fold in
NIH3T3 ﬁbroblasts in response to heat-shock. Morgana/Chp-1 gene
expression was reported previously to be controlled by HSF-1
transcription factor in response to temperature stress [9,10]. In a
genome-wide study Trinklein et al. [9] identiﬁed over 400 genes,
whose promoters bind HSF-1 and/orwhose expression is upregulated
in response to heat-shock in K562 human erythroleukemia cell line.
Morgana/Chp-1 was ranked at 90th position of the list with a 2-fold
mRNA induction.
We also found that morgana/Chp-1 mRNA is upregulated about
2.5-fold in gerbil hippocampus after transient global brain ischemia.
Interestingly, a prolonged induction of morgana/Chp-1 transcript is
observed in the naturally ischemia-resistant CA2–4 and DG regions of
the hippocampus, while in the ischemia-vulnerable CA1 region this
increase is short lasting.
The mechanism of the morgana/CHP-1 dependent cytoprotection
might be related to the protein intrinsic chaperone activity as well as
to its role as an HSP90 co-chaperone. Provided the fact that the
increase of morgana/CHP-1 in response to heat-shock is rather small,
it is unlikely that the protein's major role would be to preventaggregation of large amounts of denatured cytosolic proteins.
However, it seems justiﬁed to propose that morgana/CHP-1 can
serve as a chaperone for its thermolabile partner proteins and thus
enable their proper functioning, which is necessary for cell survival.
Moreover, like other co-chaperones, morgana/CHP-1 can possibly
direct the action of the HSP90 chaperone machinery on particular
signaling mediators, regulating their conformation and activation/
inactivation status. We have recently demonstrated that morgana/
CHP-1 binds to ROCK and inhibits its kinase activity [1]. Moreover,
ROCK is known to accelerate and amplify apoptotic cascades under
stress condition and ROCK inhibitors have pro-survival effects in
different pathological states [26]. Interestingly, a recent study
demonstrates that ROCK chemical inhibitor Y27632 provides strong
neuroprotection of hippocampal CA1 neurons in murine organotypic
hippocampal cultures subjected to in vitro ischemia [27]. As morgana/
CHP-1 inhibits ROCK kinase activity [1], it is tempting to speculate that
it might be a component of a cytoprotective mechanism in neurons of
ischemia-resistant regions of the hippocampus.
In conclusion we postulate that morgana/CHP-1 is a novel
chaperone, which acts in concert with other heat shock proteins to
protect cells from stress-induced damage.Acknowledgments
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